Revvity (NYSE:RVTY) executives said the company ended 2025 with results that exceeded internal expectations, helped by better ...
AgomAb Therapeutics NV (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on ...
OXNARD, CA / ACCESS Newswire / February 2, 2026 / Quality Dental Services functions as a foundational component supplier ...
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects ...
This cat was born looking permanently unimpressed. Thanks to some wild fur markings, this cat appears to have thick eyebrows ...
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
Lenzing Group has acquired a controlling majority stake in Swedish innovation company TreeToTextile AB through a share issuance, strengthening its position in sustainable, wood-based specialty fibers ...